(Q69173218)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference

1 reference

R C Leonard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

G E Smart

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

J R Livingstone

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

M A Cornbleet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

G R Kerr

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

S Fletcher

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

J N Webb

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

J F Smyth

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

29 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

105-110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00273526

29 September 2019

exact match

0 references

cites work

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

12 December 2020

Chemotherapy of ovarian cancer

1 reference

12 December 2020

A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer

1 reference

12 December 2020

Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)

1 reference

12 December 2020

Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line

1 reference

12 December 2020

Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone

1 reference

12 December 2020

Phase II study of Leo 1031 (prednimustine) in advanced ovarian carcinoma

1 reference

12 December 2020

Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma

1 reference

12 December 2020

Studies on the toxicity and antitumour activity of prednimustine, a prednisolone ester of chlorambucil

1 reference

12 December 2020

Prognosis of surgically determined complete responders in advanced ovarian cancer

1 reference

12 December 2020

Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy

1 reference

12 December 2020

Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer. Gruppo Interregionale Cooperativo Oncologico Ginecologia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00273526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2491962%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 September 2019

0 references

1 reference